Soumit Roy
Stock Analyst at Jones Trading
(0.65)
# 3,716
Out of 4,810 analysts
38
Total ratings
14.29%
Success rate
-12.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MURA Mural Oncology | Downgrades: Hold | n/a | $2.41 | - | 2 | Mar 25, 2025 | |
| CRVO CervoMed | Upgrades: Buy | $15 | $9.72 | +54.32% | 3 | Mar 13, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $10 | $2.02 | +395.05% | 1 | Mar 12, 2025 | |
| BEAM Beam Therapeutics | Upgrades: Buy | $34 | $17.28 | +96.76% | 2 | Mar 10, 2025 | |
| CMRX Chimerix | Downgrades: Hold | $8.55 | $8.55 | - | 1 | Mar 6, 2025 | |
| INAB IN8bio | Upgrades: Buy | $1.2 | $0.16 | +635.29% | 4 | Feb 11, 2025 | |
| OKUR OnKure Therapeutics | Initiates: Buy | $32 | $3.00 | +966.67% | 1 | Jan 28, 2025 | |
| EPIX ESSA Pharma | Downgrades: Hold | n/a | $1.63 | - | 1 | Nov 1, 2024 | |
| ELTX Elicio Therapeutics | Initiates: Buy | $9 | $4.98 | +80.72% | 1 | Oct 31, 2024 | |
| ELVN Enliven Therapeutics | Initiates: Buy | $36 | $17.05 | +111.14% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $5.04 | +237.30% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $1.35 | +862.96% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $4 | $0.59 | +576.13% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.43 | - | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.35 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $7.80 | +233.33% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $29.06 | +140.88% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $38.36 | -73.93% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $2.15 | +1,109.30% | 1 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.57 | +1,471.78% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.61 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $9.32 | +758.37% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.90 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $8.36 | +3,730.04% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $5.52 | +14,573.91% | 1 | Feb 24, 2021 |
Mural Oncology
Mar 25, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.41
Upside: -
CervoMed
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $9.72
Upside: +54.32%
Nuvation Bio
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $2.02
Upside: +395.05%
Beam Therapeutics
Mar 10, 2025
Upgrades: Buy
Price Target: $34
Current: $17.28
Upside: +96.76%
Chimerix
Mar 6, 2025
Downgrades: Hold
Price Target: $8.55
Current: $8.55
Upside: -
IN8bio
Feb 11, 2025
Upgrades: Buy
Price Target: $1.2
Current: $0.16
Upside: +635.29%
OnKure Therapeutics
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $3.00
Upside: +966.67%
ESSA Pharma
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.63
Upside: -
Elicio Therapeutics
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $4.98
Upside: +80.72%
Enliven Therapeutics
Oct 31, 2024
Initiates: Buy
Price Target: $36
Current: $17.05
Upside: +111.14%
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $5.04
Upside: +237.30%
Sep 17, 2024
Initiates: Buy
Price Target: $13
Current: $1.35
Upside: +862.96%
Sep 11, 2024
Maintains: Buy
Price Target: $6 → $4
Current: $0.59
Upside: +576.13%
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.43
Upside: -
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.35
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $7.80
Upside: +233.33%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $29.06
Upside: +140.88%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $38.36
Upside: -73.93%
Aug 18, 2023
Initiates: Buy
Price Target: $26
Current: $2.15
Upside: +1,109.30%
May 24, 2023
Initiates: Buy
Price Target: $9
Current: $0.57
Upside: +1,471.78%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.61
Upside: -
Apr 19, 2023
Initiates: Buy
Price Target: $80
Current: $9.32
Upside: +758.37%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.90
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $320
Current: $8.36
Upside: +3,730.04%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $5.52
Upside: +14,573.91%